Molnupiravir, 99.94%
cas: 2492423-29-5 — see every product listed under this CAS number, including other names
Molnupiravir, 99.94% (CAS 2492423-29-5) is a chemical reagent available from Chemat. Available pack sizes: 50 mg, 10mM/1mL, 200 mg, 100 mg, 1 g, 10 mg, 500 mg, 25 mg. Offered by: MedChemExpress.
| brand | MedChemExpress |
|---|---|
| catalog number | HY-135853-50 mg |
| cas | 2492423-29-5 |
| size | 50 mg |
| availability | In stock |
Need more information?
Ask us about this product — we're happy to help.
Available pack sizes
| brand | size | price | |
|---|---|---|---|
| MedChemExpress | 50 mg | 839.82 Pln | |
| MedChemExpress | 10mM/1mL | 491.52 Pln | |
| MedChemExpress | 200 mg | 2279.46 Pln | |
| MedChemExpress | 100 mg | 1318.15 Pln | |
| MedChemExpress | 1 g | 7555.04 Pln | |
| MedChemExpress | 10 mg | 454.37 Pln | |
| MedChemExpress | 500 mg | 4675.76 Pln | |
| MedChemExpress | 25 mg | 551.89 Pln | |
| MedChemExpress | 5 mg | 333.62 Pln |
properties
| delivery time | 1-2 weeks |
|---|---|
| purity | 99.94% |
Molnupiravir is a nucleoside analogue that is N4-hydroxycytidine in which the 5'-hydroxy group is replaced by a (2-methylpropanoyl)oxy group. It is the prodrug of the active antiviral ribonucleoside analog N4-hydroxycytidine (EIDD-1931), has activity against a number of RNA viruses including SARS-CoV-2, MERS-CoV, and seasonal and pandemic influenza viruses. It is currently in phase III trials for the treatment of patients with COVID-19. It has a role as an anticoronaviral agent, an antiviral drug and a prodrug. It is a ketoxime, an isopropyl ester and a nucleoside analogue. It is functionally related to a N(4)-hydroxycytidine.
Source: ChEBI
| Molecular formula | C13H19N3O7 |
|---|---|
| Molecular weight | 329.31 g/mol |
| IUPAC name | [(2R,3S,4R,5R)-3,4-dihydroxy-5-[4-(hydroxyamino)-2-oxopyrimidin-1-yl]oxolan-2-yl]methyl 2-methylpropanoate |
| InChIKey | HTNPEHXGEKVIHG-QCNRFFRDSA-N |
| SMILES | CC(C)C(=O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=CC(=NC2=O)NO)O)O |
Computed by PubChem (NCBI)
Synonyms:
molnupiravir, Lagevrio, Uridine, 4-oxime, 5'-(2-methylpropanoate), Eidd 1931-isopropyl ester, beta-D-N4 Hydroxycytidine-5'-isopropyl ester, N4-Hydroxycytidine, 5'-isopropyl ester, Uridine, 4-oxime, 5'-(2-methylpropanoate), (4Z)-, SARS-CoV-2 antiviral agents: molnupiravir, Molnupiravir [INN], Molnupiravir [USAN]